Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease

<div>Difference of serum PGRN (a) and EphA2 (b) levels and Gensini score (c) and LVEF (d) between patients with the acute coronary syndrome (ACS) and (SAP) and control subjects.</div>

Disease Markers

fig1

Figure 1

Figure 1: Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease 

Figure 1 | Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease 